Location: United States, Washington, Seattle
Employees: 1-10
Total raised: $76.1M
Founded date: 2018
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors |
| 26.06.2023 | Series B | $53M | - |
| 14.01.2021 | Series A | $23.1M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 26.06.2023 | AltPep Closes $53M Series B Financing | AltPep, a Seattle, WA-based biotechnology company, raised $53M in Series B funding. The round was l... | finsmes.co... |
| 22.06.2023 | AltPep Closes $52.9M Series B Round | SEATTLE, WA, AltPep today announced the completion of a $52.9 million Series B financing round. &... | vcnewsdail... |
| 29.09.2022 | Promising data from large Alzheimer’s study bodes well for t... | AltPep CEO and founder Valerie Daggett. (AltPep Photo) Alzheimer’s disease researchers were buoyed ... | geekwire.c... |
| 22.08.2022 | Seattle startup aiming to detect, treat Alzheimer’s and Park... | AltPep CEO and founder Valerie Daggett. (AltPep Photo) The news: University of Washington spinout A... | geekwire.c... |
| 15.01.2021 | AltPep Raises $23M in Series A | SEATTLE, WA, AltPep announced it closed a $23.150 million Series A investment round led by Matrix ... | vcnewsdail... |
| 14.01.2021 | Seattle biotech startup AltPep raises $23.1M to tackle Alzhe... | Valerie Daggett, founder and CEO of AltPep. (UW Photo) AltPep, a Seattle-based biotech startup tack... | geekwire.c... |
| 14.01.2021 | AltPep Raises $23M Jumpstarting Work on Alzheimer's Disease | SEATTLE, Jan. 14, 2021 /PRNewswire/ -- AltPep Corporation, a privately held biomedical company foc... | prnewswire... |
| - | AltPep | “parkinson's disease, Parkinson's disease, Alzheimer's disease, alzheimer's disease, alzheimer's, di... | fastfounde... |